Immunovant (IMVT) Interest Coverage Ratio (2019 - 2026)
Immunovant (IMVT) posted Interest Coverage Ratio of 597.02 for Q1 2026, down 861824.77% on a QoQ basis from 0.07 in Q4 2025, and down 115766.74% year-over-year from N/an in Q1 2025.
Immunovant (IMVT) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Immunovant's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 597.02 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 115766.74% year-over-year to 597.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1055.68 (down 53005.19% YoY) and the FY2026 annual result came in at 0.62, up 30.15% from the prior year.
- Interest Coverage Ratio was 597.02 for Q1 2026 at Immunovant, down from 0.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.88 in Q4 2023 and bottomed at 3077.54 in Q2 2022.
- A 5-year average of 232.7 and a median of 0.07 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 104.36% — and 2026, when it slumped 115766.74%.
- Immunovant's Interest Coverage Ratio stood at 0.45 in 2022, then jumped by 94.9% to 0.88 in 2023, then sank by 56.85% to 0.38 in 2024, then tumbled by 81.75% to 0.07 in 2025, then sank by 861824.77% to 597.02 in 2026.
- Business Quant data shows IMVT's Interest Coverage Ratio at 597.02 in Q1 2026, 0.07 in Q4 2025, and 1.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - | -597.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -597.02 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | -1.62 |
| Jun 30, 2025 | -0.62 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | -21.33 |
| Dec 31, 2023 | 0.88 |
| Sep 30, 2023 | 0.85 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | -28.59 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | -19.54 |
| Jun 30, 2022 | -3,077.54 |
| Mar 31, 2022 | -214.45 |
| Dec 31, 2021 | -24.27 |
| Sep 30, 2021 | -15.29 |
| Jun 30, 2021 | -2.75 |